HIGH BODY MASS INDEX (BMI) IS ASSOCIATED WITH ADIPOKINES AND INSULIN RESISTANCE IN NONDIALYSED CHRONIC KIDNEY DISEASE (CKD) PATIENTS

The aim of this study was to assess the association between body adiposity with adipokines and with insulin resistance in non-dialysed CKD patients. This is a cross-sectional study including CKD patients under regular treatment in an outpatient clinic. Glomerular filtration rate was estimated by MDR...

Full description

Saved in:
Bibliographic Details
Published inKidney research and clinical practice Vol. 31; no. 2; p. A19
Main Authors Inês Barreto-Silva, Maria, Avesani, Carla, Kawakami, Laura, Martucci, Renata, Bregman, Rachel
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.06.2012
The Korean Society of Nephrology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this study was to assess the association between body adiposity with adipokines and with insulin resistance in non-dialysed CKD patients. This is a cross-sectional study including CKD patients under regular treatment in an outpatient clinic. Glomerular filtration rate was estimated by MDRD equation (eGFR). The nutritional status was assessed by BMI, total body fat (BF; dual-energy X-ray absorptiometry), midarm muscle circumference and serum albumin. Laboratorial parameters included serum glucose, triglycerides; leptin and insulin (radioimmunoassay); high molecular weight adiponectin (HMWAdipo; ELISA). The insulin resistance was assessed by HOMA-IR. Data are expressed as mean + SD. One hundred and thirty four CKD patients (male=56%; eGFR= 29±13ml/min.; 65±12 years old) were included. None of the patients presented protein energy wasting and most of them had BMI≥25kg/m2 (overweight/obese group: OwOb) ( n = 72; 54%). BMI was correlated with BF ( r = 0.74; p<0.0001). Both BMI groups showed similar eGFR and CKD stages distribution (stage 3:42%, 4: 37%, 5: 21%), hence the comparisons were held between groups with normal and OwOb BMI. The OwOb group had BMI, BF, glucose, triglycerides, leptin and HOMA-IR higher than normal BMI group (P<0.05), while HMWAdipo was lower in OwOb group (P<0.05). BMI was significantly associated with leptin ( r = 0.58); HOMA-IR ( r = 0.36) and HMWAdipo ( r = −0.45). HOMA-IR was associated with leptin ( r = 0.28) and with HMWAdipo ( r = −0.29) (P<0.01), even after adjusting for BF, eGFR, gender and age. In conclusion, BMI and BF were associated with increased leptin and HOMA-IR, but with decreased HMWAdipo. The OwOb CKD patients presented higher risk for metabolic and cardiovascular disorders.
ISSN:2211-9132
DOI:10.1016/j.krcp.2012.04.336